---
document_datetime: 2023-09-21 21:05:08
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rasilez-hct-epar-all-authorised-presentations_en.pdf
document_name: rasilez-hct-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 5.8923738
conversion_datetime: 2025-12-23 01:44:52.400905
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name                      | Strength                             | Pharmaceutical Form        | Route of Administration   | Immediate Packaging authorised   | Pack size                                       |
|------------------|--------------------------------------|--------------------------------------|----------------------------|---------------------------|----------------------------------|-------------------------------------------------|
| EU/1/08/491/001  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 7 tablets                                       |
| EU/1/08/491/002  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 14 tablets                                      |
| EU/1/08/491/003  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 28 tablets                                      |
| EU/1/08/491/004  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 30 tablets                                      |
| EU/1/08/491/005  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 50 tablets                                      |
| EU/1/08/491/006  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 56 tablets                                      |
| EU/1/08/491/007  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 90 (3 x 30) tablets (multipack)                 |
| EU/1/08/491/008  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 98 (2 x 49) tablets (multipack)                 |
| EU/1/08/491/009  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use longer           | blister (PA/Alu/PVC)             | 280 (20 x 14) tablets (multipack)               |
| EU/1/08/491/010  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PCTFE/PVC)              | 7 tablets                                       |
| EU/1/08/491/011  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PCTFE/PVC)              | 14 tablets                                      |
| EU/1/08/491/012  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PCTFE/PVC)              | 28 tablets                                      |
| EU/1/08/491/013  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PCTFE/PVC)              | 30 tablets                                      |
| EU/1/08/491/014  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet no      | Oral use                  | blister (PCTFE/PVC)              | 50 tablets                                      |
| EU/1/08/491/015  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PCTFE/PVC)              | 56 tablets                                      |
| EU/1/08/491/016  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet Product | Oral use                  | blister (PCTFE/PVC)              | 56 x 1 tablets (unit dose)                      |
| EU/1/08/491/017  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PCTFE/PVC)              | 90 tablets                                      |
| EU/1/08/491/018  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PCTFE/PVC)              | 98 tablets                                      |
| EU/1/08/491/019  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PCTFE/PVC)              | 98 (2 x 49 x 1) tablets (unit dose) (multipack) |
| EU/1/08/491/020  | Rasilez HCT                          | 150 mg / 12.5 mg                     | Film-coated tablet         | Oral use                  | blister (PCTFE/PVC)              | 280 (20 x 14) tablets (multipack)               |
| EU/1/08/491/021  | Rasilez HCT                          | 150 mg / 25 mg                       | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 7 tablets                                       |
| EU/1/08/491/022  | Rasilez HCT                          | 150 mg / 25 mg                       | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 14 tablets                                      |
| EU/1/08/491/023  | Rasilez HCT                          | 150 mg / 25 mg                       | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 28 tablets                                      |
| EU/1/08/491/024  | Rasilez HCT                          | 150 mg / 25 mg                       | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 30 tablets                                      |
| EU/1/08/491/025  | Rasilez HCT                          | 150 mg / 25 mg                       | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 50 tablets                                      |
| EU/1/08/491/026  | Rasilez HCT                          | 150 mg / 25 mg                       | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 56 tablets                                      |
| EU/1/08/491/027  | Rasilez HCT                          | 150 mg / 25 mg                       | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 90 (3 x 30) tablets (multipack)                 |
| EU/1/08/491/028  | Rasilez HCT 150 mg / 25 mg Medicinal | Rasilez HCT 150 mg / 25 mg Medicinal | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 98 (2 x 49) tablets (multipack)                 |
| EU/1/08/491/029  | Rasilez HCT 150 mg / 25 mg           | Rasilez HCT 150 mg / 25 mg           | Film-coated tablet         | Oral use                  | blister (PA/Alu/PVC)             | 280 (20 x 14) tablets (multipack)               |

<div style=\"page-break-after: always\"></div>

| EU/1/08/491/030   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use        | blister (PCTFE/PVC) authorised   | 7 tablets                                       |
|-------------------|---------------|----------------------------|----------------------------|-----------------|----------------------------------|-------------------------------------------------|
| EU/1/08/491/031   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 14 tablets                                      |
| EU/1/08/491/032   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 28 tablets                                      |
| EU/1/08/491/033   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 30 tablets                                      |
| EU/1/08/491/034   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 50 tablets                                      |
| EU/1/08/491/035   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 56 tablets                                      |
| EU/1/08/491/036   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 56 x 1 tablets (unit dose)                      |
| EU/1/08/491/037   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 90 tablets                                      |
| EU/1/08/491/038   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 98 tablets                                      |
| EU/1/08/491/039   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 98 (2 x 49 x 1) tablets (unit dose) (multipack) |
| EU/1/08/491/040   | Rasilez HCT   | 150 mg / 25 mg             | Film-coated tablet         | Oral use longer | blister (PCTFE/PVC)              | 280 (20 x 14) tablets (multipack)               |
| EU/1/08/491/041   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)             | 7 tablets                                       |
| EU/1/08/491/042   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)             | 14 tablets                                      |
| EU/1/08/491/043   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)             | 28 tablets                                      |
| EU/1/08/491/044   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)             | 30 tablets                                      |
| EU/1/08/491/045   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)             | 50 tablets                                      |
| EU/1/08/491/046   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)             | 56 tablets                                      |
| EU/1/08/491/047   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet no      | Oral use        | blister (PA/Alu/PVC)             | 90 (3 x 30) tablets (multipack)                 |
| EU/1/08/491/048   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PA/Alu/PVC)             | 98 (2 x 49) tablets (multipack)                 |
| EU/1/08/491/049   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet Product | Oral use        | blister (PA/Alu/PVC)             | 280 (20 x 14) tablets (multipack)               |
| EU/1/08/491/050   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 7 tablets                                       |
| EU/1/08/491/051   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 14 tablets                                      |
| EU/1/08/491/052   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 28 tablets                                      |
| EU/1/08/491/053   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 30 tablets                                      |
| EU/1/08/491/054   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 50 tablets                                      |
| EU/1/08/491/055   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 56 tablets                                      |
| EU/1/08/491/056   | Rasilez HCT   | 300 mg / 12.5 mg Medicinal | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 56 x 1 tablets (unit dose)                      |
| EU/1/08/491/057   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 90 tablets                                      |
| EU/1/08/491/058   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 98 tablets                                      |
| EU/1/08/491/059   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 98 (2 x 49 x 1) tablets                         |
| EU/1/08/491/060   | Rasilez HCT   | 300 mg / 12.5 mg           | Film-coated tablet         | Oral use        | blister (PCTFE/PVC)              | 280 (20 x 14) tablets (multipack)               |

<div style=\"page-break-after: always\"></div>

EU/1/08/491/061

EU/1/08/491/062

EU/1/08/491/063

EU/1/08/491/064

EU/1/08/491/065

EU/1/08/491/066

EU/1/08/491/067

EU/1/08/491/068

EU/1/08/491/069

EU/1/08/491/070

EU/1/08/491/071

EU/1/08/491/072

EU/1/08/491/073

EU/1/08/491/074

EU/1/08/491/075

EU/1/08/491/076

EU/1/08/491/077

EU/1/08/491/078

EU/1/08/491/079

EU/1/08/491/080

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

Rasilez HCT

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

300 mg / 25 mg

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Film-coated tablet

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use blister (PA/Alu/PVC)

blister (PA/Alu/PVC)

blister (PA/Alu/PVC)

blister (PA/Alu/PVC)

blister (PA/Alu/PVC)

blister (PA/Alu/PVC)

blister (PA/Alu/PVC)

blister (PA/Alu/PVC)

blister (PA/Alu/PVC)

blister (PCTFE/PVC)

blister (PCTFE/PVC)

blister (PCTFE/PVC)

blister (PCTFE/PVC)

blister (PCTFE/PVC)

blister (PCTFE/PVC)

blister (PCTFE/PVC)

blister (PCTFE/PVC)

blister (PCTFE/PVC)

blister (PCTFE/PVC)

blister (PCTFE/PVC)

7 tablets 14 tablets 28 tablets 30 tablets 50 tablets 56 tablets 90 (3 x 30) tablets (multipack) 98 (2 x 49) tablets (multipack) 280 (20 x 14) tablets (multipack) 7 tablets 14 tablets 28 tablets 30 tablets 50 tablets 56 tablets 56 x 1 tablets (unit dose) 90 tablets 98 tablets 98 (2 x 49 x 1) tablets (unit dose) (multipack) 280 (20 x 14) tablets (multipack)

Medicinal Product no longer authorised